Post-mortem evaluation after oncological treatment of the functional and bacteriological status of 25 permanent venous access devices;Evaluation post-mortem apres traitement oncologique de l'etat fonctionnel et bacteriologique de 25 acces veineux permanents

Schweizerische Medizinische Wochenschrift

Volumn 128, Issue 36, 1998, Pages 1334-1338

  Groebli, Y ^a   Bartolomei, J ^a   Wuthrich P ^a   Callewaert, G ^a   Tschantz, P ^a   Piguet, D ^a  

^a Hopital Pourtales Neuchatelois   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COAGULASE;

ADULT; AGED; ARTICLE; AUTOPSY; BLOOD CULTURE; CADAVER; CLINICAL ARTICLE; DEVICE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION COMPLICATION; MALE; MORBIDITY; PREVALENCE; STAPHYLOCOCCUS; VASCULAR ACCESS; BACTEREMIA; CENTRAL VENOUS CATHETERIZATION; CROSS INFECTION; DISEASE TRANSMISSION; EQUIPMENT; INDWELLING CATHETER; INSTRUMENTATION; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; NEOPLASM; PATHOLOGY; RISK FACTOR; STAPHYLOCOCCUS INFECTION;

ADULT; AGED; BACTEREMIA; BACTERIOLOGICAL TECHNIQUES; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CROSS INFECTION; EQUIPMENT CONTAMINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS;

EID: 0032487020     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Broviac JW, Cole JJ, Scribner BH. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet 1973;136:602-6.
2. Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 1982;92:706-11.
3. Wright KC, Szwarc IA, Colins RD, Gianturco C. A new subcutaneous vascular access device: an experimental evaluation. Radiology 1983;146:222-3.
4. Banios CH, Zuke JE, Blaes B, Hirsch JD, Lyss AP. Evaluation of an implantable venous access system in a general oncology population. Oncology 1992;49:474-8.
5. Brothers TE, Moll LK, Niederhuber JE, Roberts JA, Walkey-Andrews S, Ensminger WD. Experience with subcutaneous infusion ports in three hundred patients. Surg Gynecol Obstet 1988;166:295-301.
6. Grannan KJ, Taylor PH. Early and late complications of totally implantable venous access devices. J Surg Oncol 1990; 44:52-4.
7. Leclerc YE, Loutfi A. Implantable device for venous access. Can J Surg 1987;30:127-9.
8. Laurenzi L, Fimiani C, Faglieri N, Natoli S, Chilosi G, Tirelli W, et al. Complications with fully implantable venous access systems in oncologic - patients. Tumori 1996;82:232-6.
9. Champault G. Totally implantable catheters for cancer chemotherapy: french experience on 325 cases. Cancer Drug Deliv 1986;3:131-7.
10. Poorter RL, Lauw FN, Bemelman WA, Bakker PJ, Taat CV, Veenhof CH. Complications of an implantable venous access device (Port-Cath) during intermittent continuous infusion of chemotherapy. Eur J Cancer 1996;32A:2262-6.
11. Schwarz RE, Groeger JS, Coit DG. Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis. Cancer 1997;79:1635-40.
12. Sattler FR, Foderado JB, Aber RC. Staphylococcus epidermidis bacteremia associated with vascular catheters: an important cause of febrile morbidity in hospitalized patients. Infect Control 1984;5:279-83.
13. Jacobs MB, Yeager M. Thrombotic and infectious complications of Hickman-Broviac catheters. Arch Intern Med 1984; 144:1597-9.
14. Kappers-Klunne MC, Degener JE, Stijnen T, Abels J. Complications from long-term indwelling central venous catheters in hematologic patients with special reference to infection. Cancer 1989;64:1747-52.
15. Vlasveld LT, Rodenhuis S, Rutgers EJ, Dubbelman AC, Hilton AM, Batchelor D, et al. Catheter-related complications in 52 patients treated with continuous infusion of low dose recombinant interleukin-2 via an implanted central venous catheter. Eur J Surg Oncol 1994;20:122-9.
16. Cowan CE. Antibiotic lock technique. J Intrav Nurs 1992; 15,5:283-7.
17. Kock HJ, Krause U, Pietsch M, Rasfeld S, Walz MK. Implantable catheter systems. Experiences with 1000 patients with central venous ports. Dtsch Med Wochenschr 1996; 121:47-51.
18. Dega H, Eliaszewicz M, Gisselbrecht M, Fleury J, Pialoux G, Janssen B, et al. Infections associated with totally implantable venous access devices (TIVAD) in human immunodeficiency virus-infected patients. J Acquir Immune Defic Syndr 1996;13,2:145-54.
19. Armbruster C, Armbruster C, Kriwanek S. Totally implantable, permanent central venous catheter systems in Aids-patients - a method for home care or on unacceptable infection risk? Schweiz Med Wochenschr 1996;126:1597-602.
20. Brincker H, Saeter G. Fifty-five patient years experience with a totally implanted system for intravenous chemotherapy. Cancer 1986;57:1124-9.
21. Barnes JR, Lucas N, Broedwater JR, Hauer-Jensen M. When should the «infected» subcutaneous infusion reservoir be removed? Am Surg 1996;62:203-6.
22. Guillet P, La Scola B, Bagarry-Liegey D, Lorvellec K, Martin N, Nicoara A, et al. Clinical pilot study on repeated use of heparin, vancomycin, colimycine locked flush solution for central intravenous implanted catheter in oncology. Pathol Biol 1997;45:506-13.
23. Ruble H, Juricic M, Claeyssens S, Krimou A, Lemozy J, Izard P. Morbidity using subcutaneous ports efficacy of vancomycin flushing in cancer. Arch Dis Child 1995;72:325-9.